Skip to main content
. 2021 May 17;106(9):e3519–e3532. doi: 10.1210/clinem/dgab320

Figure 4.

Figure 4.

Effect of fezolinetant on A, AMH and B, adjusted mean change in ovarian volume based on transvaginal ultrasound at week 12, ITT population. AMH, antimüllerian hormone; ITT, intent-to-treat.